Amphenol returns the remainder of its excess capital to shareholders. Amphenol pays a quarterly dividend, and has maintained a dividend payout ratio above 25% since 2019. Amphenol also conducts ...

India's equity market is rebounding due to easing geopolitical tensions, strong earnings, and investor inflows. IPO momentum ...

Agilent's Morningstar Uncertainty Rating remains Medium, thanks to its sticky end markets that should result in relatively steady demand trends in the long run, despite its dependence on one-time ...

Buffer strategies have experienced notable investor interest amid the 2025 bout of equity market volatility. Click to read.

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

While Indian banks are benefitting from emerging trends like mutual fund distribution and insurance sales, much of the fee ...

Although ILS Gummies produces 60 million nutraceutical gummies monthly in McKinney, the demand is over double that amount. A ...

Luria’s theory is that the energy of God’s explosive radiation of creation, when confined in material containers (vessels) shattered the vessels and produced the spiritually and morally differentiated ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Dipan Mehta of Elixir Equities notes a mixed earnings season with disappointments in major sectors like banking and software.

REGENXBIO retains additional potential non-dilutive funding opportunities, including monetization of Priority Review Voucher (PRV) and milestones from AbbVie ROCKVILLE, Md., May 19, 2025 /PRNewswire/ ...